Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...
Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback